Boston Scientific (BSX)

R&D Expense Growth

7.36%

Quarterly · Period ending:

BSX logo

BSX R&D Expense Growth

Latest reported7.36%
BSX Quarterly R&D Growth (QoQ) (0.00% → 7.36%)
High-resolution chart · PNG

BSX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
26.7857%
5.6604%
10.4167%
-2.0408%
0%
-3.9216%
6.25%
-2.0408%
0%
-93.3712%
1,387.3239%
2.2634%
8.9686%
-39.4022%
69.9769%
5.6098%
21.6617%
0%
-100%
5.5749%
11.2403%
0%
-100%
6.7073%
3.7975%
116.4384%
1.3889%
-5.2632%
1.3333%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.